APA’s 2017 Consensus on Ketamine: A Paradigm Shift in Treating Mood Disorders
Introduction:The 2017 consensus statement by the APA Council of Research Task Force on Novel Biomarkers and Treatments, led by Sanacora […]
Problem
New Hope for Depression: What Experts Say About Ketamine (APA, 2017)
Introduction:A groundbreaking 2017 report by the American Psychiatric Association (APA) sheds light on the use of ketamine to treat mood
Preparing for Psychedelic Therapy: What It Takes (2024 Study)
Introduction:Psychedelic treatments for mental health issues, like depression and PTSD, are gaining attention for their potential to help when other
Drug-Drug Interactions Between Purified CBD and ASM: Final Analysis (Gaston et al., 2023)
Introduction:In a 2023 study published in Epilepsia Open, Gaston et al. provided a comprehensive analysis of potential drug-drug interactions (DDIs)
CBD and Seizure Medications: What You Need to Know (2023 Study)
Introduction:A 2023 study published in Epilepsia Open by Dr. Gaston and colleagues examined how cannabidiol (CBD) interacts with common seizure
What It Means for Healthcare Providers
As ketamine gains recognition for its potential in treating conditions like treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD), and chronic
A Patient’s Guide to Ketamine-Assisted Psychotherapy
If you’re exploring new treatments for depression, anxiety, or PTSD, you may have heard about ketamine therapy—a unique approach that’s
What It Means for Patients
Ketamine, once primarily known as an anesthetic, has emerged as a promising treatment for conditions like treatment-resistant depression, chronic pain,
A Guide for Healthcare Providers Interested in Offering Ketamine-Assisted Psychotherapy
Ketamine-assisted psychotherapy (KAP) is emerging as a powerful tool for treating mental health conditions such as treatment-resistant depression, post-traumatic stress